来那度胺是由Celgene公司研发并上市的一种免疫调节药,是医药领域的超级重磅炸弹式药物。本文对来那度胺相关专利申请进行了分析,并深入解读了原研企业的专利申请与专利布局策略,对比分析了竞争企业的专利挑战策略,为国内医药研发机构及有关企业对来那度胺的研究开发提供参考。 Lenalidomide, an immunomodulatory drug developed and marketed by Celgene, is a super blockbuster drug in the medical field. This article analyzes the patent applications of lenalidomide and deeply analyzes the patent application and patent layout strategies of the original research enterprises, compares and analyzes the patent challenge strategies of the competing enterprises, and provides a theoretical basis for the domestic pharmaceutical R & D institutions and related enterprises to conduct lenalidomide Research and development to provide a reference.